Company Profile
Allergy Therapeutics plc, a commercial biotechnology company focuses on the diagnosis and treatment of allergic disorders globally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees Diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus.
It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen VLP Peanut, a short-course peanut allergy vaccine. Founded in 1998, Allergy Therapeutics is headquartered in Worthing, the United Kingdom.